Medical Devices News and Research

RSS

Graphene breakthrough offers hope against antibiotic-resistant infections

With strong bactericidal properties, graphene has the potential to become a game changer in the fight against antibiotic-resistant bacteria.

24 Sep 2024

Survey reveals significant gaps in global pandemic preparedness

Abbott announced the findings of a new survey; among leading infectious disease experts around the world on the state of pandemic preparedness and found that while most agree that preparation has improved since the COVID-19 pandemic, respondents say significant gaps remain in building surveillance programs to identify emerging pathogens, public health funding and having adequate testing infrastructure capabilities.

18 Sep 2024

Mpox inactivated in 60 seconds with Σ-MM™ & patient friendly collection swab

In the wake of the global Mpox outbreak in non-endemic countries in 2022, the medical community has been searching for safer and more efficient ways to transport and test virus samples, especially from patients in areas with limited biological containment facilities.

From Medical Wire 6 Sep 2024

APDI provides $200,000 in grants to advance pediatric substance use disorder devices

The Alliance for Pediatric Device Innovation (APDI), a nonprofit consortium led by Children's National Hospital and funded through the Food and Drug Administration (FDA), announces today the recipients of grants totaling $200,000 to advance pediatric medical devices that improve the monitoring, diagnosis or treatment of youth suffering from substance use disorder and addiction.

4 Sep 2024

Graylight imaging is ISO 13485 certified

In November 2023, we are proud to announce that we, Graylight Imaging, have successfully achieved ISO 13485 certified status, demonstrating our commitment to the highest quality standards in the design and manufacture of medical devices.

From Graylight Imaging 28 Aug 2024

New benchmark: 1 kg of plasmid DNA manufactured

Kaneka Eurogentec sets new benchmark in plasmid DNA manufacturing with the production of 1 kg of plasmid DNA.

From Kaneka Eurogentec S.A 27 Aug 2024

Almost half of FDA-approved medical AI devices lack clinical validation data

Artificial intelligence (AI) has practically limitless applications in healthcare, ranging from auto-drafting patient messages in MyChart to optimizing organ transplantation and improving tumor removal accuracy.

26 Aug 2024

ADA and Abbott join forces to address nutritional needs in diabetes and obesity

The American Diabetes Association® (ADA) and Abbott recently announced a collaboration to better understand the nutritional needs of people living with diabetes, obesity, and metabolic dysfunction and how nutrition formulas can support those needs and overall health.

21 Aug 2024

The FDA calls them ‘recalls,’ yet the targeted medical devices often remain in use

In 2016, medical device giant Abbott issued a recall for its MitraClip cardiac device — "a Class I recall, the most serious type," the FDA said.

15 Aug 2024

Air-powered computers can be a more reliable, cost-effective way to help prevent blood clots and strokes

A new, air-powered computer sets off alarms when certain medical devices fail. The invention is a more reliable and lower-cost way to help prevent blood clots and strokes - all without electronic sensors.

14 Aug 2024

UVA professor wins NIH Maximizing Investigator's Research Award for breakthrough biomedicine research

University of Virginia assistant engineering professor Liheng Cai has earned the Maximizing Investigator's Research Award from the National Institutes of Health.

5 Aug 2024

Texas Heart Institute and BiVACOR achieve milestone with total artificial heart implantation

The Texas Heart Institute (THI) and BiVACOR, a clinical-stage medical device company, announced today the successful first-in-human implantation of the BiVACOR Total Artificial Heart (TAH) as part of the U.S. Food and Drug Administration (FDA) Early Feasibility Study (EFS) on July 9, 2024.

25 Jul 2024

Synthetic solutions for ethical and effective drug testing

Improving human quality of life with drug treatments is a complicated issue. Drug certification, including drug safety and reliability, entails a long series of tests and government approvals before the drug is available for anyone to use.

22 Jul 2024

JH Technologies announces strategic partnership with VacTradeUK to distribute advanced vacuum coating systems in the United States

JH Technologies, a leading provider of scientific instruments and equipment, is pleased to announce a strategic partnership with VacTradeUK, a renowned manufacturer of advanced vacuum coating systems.

From JH Technologies 16 Jul 2024

Mainz Biomed seeks FDA’s Breakthrough Devices Designation for advanced colorectal cancer test

Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced that it has submitted its application to the U.S. Food and Drug Administration (FDA) requesting Breakthrough Device Designation for its non-invasive Next Generation colorectal cancer (CRC) product including the Company’s novel portfolio of mRNA biomarkers. Subject to the FDA’s review, a Breakthrough Device Designation could significantly accelerate approval.

13 Jul 2024

From Dr. Oz to heart valves: A tiny device charted a contentious path through the FDA

In 2013, the FDA approved an implantable device to treat leaky heart valves. Among its inventors was Mehmet Oz, the former television personality and former U.S. Senate candidate widely known as "Dr. Oz."

9 Jul 2024

WHO launches an online platform for information on medical devices

World Health Organization (WHO) has introduced an online platform called MeDevIS (Medical Devices Information System), the first global open access clearing house for information on medical devices.

8 Jul 2024

Insilico Medicine and Fosun Pharma deliver second preclinical candidate for solid tumor treatment

Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has successfully delivered the second preclinical candidate compound (PCC) in its collaboration with Fosun Pharma in June 2024, a potential innovative therapeutic using synthetic lethal strategy for the treatment of solid tumors.

5 Jul 2024

Pioneering Live Cell Imaging - Yokogawa's Impact and Innovations

In this interview, NewsMedical speaks with Kevin Jan from Yokogawa about the future of live cell imaging technologies.

From Yokogawa Life Science 3 Jul 2024

AI models may be using “demographic shortcuts” when making medical diagnostic evaluations

Artificial intelligence models often play a role in medical diagnoses, especially when it comes to analyzing images such as X-rays. However, studies have found that these models don't always perform well across all demographic groups, usually faring worse on women and people of color.

28 Jun 2024